← FDA DRUG APPROVALS

FDA ANDA · ANDA074030

MICONAZOLE NITRATE

Sponsor: TEVA PHARMS

APPLICATION
ANDA074030
TYPE
ANDA
ORIGINAL APPROVAL
1992-10-30
LATEST ACTION
1999-03-23
ROUTE
VAGINAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

MICONAZOLE NITRATEDiscontinued
MICONAZOLE NITRATE 2% · CREAM · VAGINAL

Approval history

1999-03-23Manufacturing (CMC) · Supplement 12AP
1998-06-11Manufacturing (CMC) · Supplement 11AP
1996-12-04Manufacturing (CMC) · Supplement 10AP
1996-05-31Manufacturing (CMC) · Supplement 8AP
1994-06-20Labeling · Supplement 7AP
1994-04-11Labeling · Supplement 6AP
1993-11-19Manufacturing (CMC) · Supplement 1AP
1993-11-05Manufacturing (CMC) · Supplement 5AP
1993-11-05Labeling · Supplement 3AP
1993-07-21Labeling · Supplement 4AP
1993-02-03Labeling · Supplement 2AP
1992-10-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →